Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platysma Prominence”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Study completedNCT05773053
What this trial is testing

NT 201 Doses in the Treatment of Platysma Prominence

Who this might be right for
Platysma Prominence
Merz Aesthetics GmbH 73
Large-scale testing (Phase 3)Study completedNCT05134649
What this trial is testing

Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Who this might be right for
Platysma Prominence
AbbVie 292
Testing effectiveness (Phase 2)Study completedNCT03915067
What this trial is testing

BOTOX® for the Treatment of Platysma Prominence

Who this might be right for
Platysma Prominence
Allergan 171
Large-scale testing (Phase 3)Study completedNCT04994535
What this trial is testing

Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence

Who this might be right for
Platysma Prominence
AbbVie 426
Large-scale testing (Phase 3)Study completedNCT04949399
What this trial is testing

Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence

Who this might be right for
Platysma Prominence
AbbVie 408
Large-scale testing (Phase 3)Active Not RecruitingNCT07210463
What this trial is testing

NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)

Who this might be right for
Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of Drugs+7 more
Merz Aesthetics GmbH 300
Large-scale testing (Phase 3)Active Not RecruitingNCT07122193
What this trial is testing

NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

Who this might be right for
Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of Drugs+7 more
Merz North America, Inc. 300